Jie Zhang | Head of Global Value and Access, Cell & Gene, Oncology
Novartis

Jie Zhang is the Head of Global Value & Access in Cell & Gene unit at Novartis Oncology. In his role, he led the development of HEOR, market access and pricing strategy for multiple disease areas including launches of Kymriah, Tafinlar/Mekinist combination, Zykadia, and Afinitor. In addition, he has more than 10 years of experiences in clinical development. He led statistical effort in multiple clinical development programs across variety of disease areas. Dr. Zhang’s work has been published in leading journals of health economics, medicine, health policy and statistics. He holds a PhD degree from North Carolina State University.